Physician profile
Margaret Carter
NPI 1396705554
$299.36
in general payments reported to CMS, 2019-2025
8 companies · $148 in 2025
The $148 reported for 2025 was more than what 76% of Maternal & Fetal Medicine providers received nationally (typical 2025 total: $55.21).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.99 · 2020: $18.30 · 2021: $13.91 · 2022: $29.10 · 2023: $17.94 · 2024: $32.41 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $83.14 | 2024-2025 | Minimed 780g |
| Boston Scientific Corporation | $56.66 | 2025 | General - Pain Management |
| Allergan, INC. | $45.87 | 2019-2022 | |
| Dexcom, INC. | $43.13 | 2023-2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $23.22 | 2019 | |
| Amag Pharmaceuticals, INC. | $18.30 | 2020 | |
| Sun Pharmaceutical Industries INC. | $15.13 | 2024 | |
| Currax Pharmaceuticals LLC | $13.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.